Skip to main content
. 2023 Jun 25;153(8):2298–2311. doi: 10.1016/j.tjnut.2023.06.027

TABLE 1.

Demographic variables at baseline based on group1,2

Variable Treatment group Control group
n 12 9
Age, y 51.6 ± 10.0 52.8 ± 8.1
Sex, n female, n male 10, 2 9, 0
Race/ethnicity, %
 Caucasian 100 77.8
 African American 0 11.1
 Latino/a 0 11.1
Highest level of education, %
 High school 8.3 0
 Some college 50 11.1
 College graduate 33.3 44.4
 After college 8.3 44.4
Years with diagnosed MS 10.3 ± 6.2 14 ± 9.04
BMI, kg/m2 29.9 ± 7.1 32.30 ± 9.00
Expanded Disabilities Scale 3.5 ± 2.4 2.78 ± 2.44
Dietary L + Z intake, mg3 2.47 ± 2.22 2.46 ± 2.11
Macular pigment optical density 0.32 ± 0.26 0.46 ± 0.27
Skin carotenoids, VM units 240 ± 57 292 ± 84
Serum lutein, μmol/L4 0.13 ± 0.06 0.19 ± 0.11

L + Z, lutein and zeaxanthin; MS, multiple sclerosis; VM, Veggie Meter.

1

Continuous data expressed as mean ± SD.

2

Baseline group equivalence was assessed at baseline using independent t tests. No significant differences were observed between the 2 groups at baseline.

3

Treatment group n = 5, control group n = 7.

4

Control group n = 8.